December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Edoxaban in cancer associated isolated distal DVT
Nov 26, 2024, 23:44

Edoxaban in cancer associated isolated distal DVT

Erman Akkus, Medical Oncology Fellow at Ankara University, shared a recent article by Yugo Yamashita on X:

“Edoxaban for 12 vs 3 months in cancer associated isolated distal DVT Oncology DVT Study at Circulation.

Symptomatic recurrent VTE or VTE-related death 1% vs 7.2% (OR: 0.13; 95% CI, 0.03–0.44) Bleeding 9.5% vs 7.2%, (OR: 1.34; 95% CI, 0.75–2.41) Cancer and treatment types (platin, beva etc) are not specified 12 vs 6 months?”

Title: Edoxaban for 12 Months Versus 3 Months in Patients with Cancer with Isolated Distal Deep Vein Thrombosis (ONCO DVT Study): An Open-Label, Multicenter, Randomized Clinical Trial

Authors: Yugo Yamashita, Takeshi Morimoto, Nao Muraoka, Takuya Oyakawa, Michihisa Umetsu, Daijirou Akamatsu, Yuji Nishimoto, Yukihito Sato, Takuma Takada, Kentaro Jujo, Yuichiro Minami, Yoshito Ogihara, Kaoru Dohi, Masashi Fujita, Tatsuya Nishikawa, Nobutaka Ikeda, Go Hashimoto, Kazunori Otsui, Kenta Mori, Daisuke Sueta, Yukari Tsubata, Masaaki Shoji, Ayumi Shikama, Yutaka Hosoi, Yasuhiro Tanabe, Ryuki Chatani, Kengo Tsukahara, Naohiko Nakanishi, Kitae Kim, Satoshi Ikeda, Makoto Mo, Yusuke Yoshikawa and Takeshi Kimura.

 

Edoxaban-cancer

Edoxaban-cancer

Edoxaban-cancer

Erman Akkus is a medical oncology fellow at the Ankara University, Faculty of Medicine. Previously, he was an Internal Medicine Resident at the Ankara University, Faculty of Medicine. He was also a Visiting Researcher at the University of Oslo. He completed his education from the Medical University of Vienna.

More posts featuring Erman Akkus.